Sabin-IPV offers a potentially safer and more affordable alternative to conventional IPV for global polio eradication efforts.
No takes yet. Share an insight, caveat, or question.
Should not yet change polio vaccination practice; leaves open Sabin-IPV's role pending controlled trials.
Verdijk et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: